Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cencora's change in inventory for the quarter that ended in Jun. 2026 was €-770 Mil. It means Cencora's inventory
increased by €770 Mil
from Mar. 2026 to Jun. 2026 .
Cencora's change in inventory for the fiscal year that ended in Sep. 2025 was €-1,082 Mil. It means Cencora's inventory
increased by €1,082 Mil
from Sep. 2024 to Sep. 2025 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cencora's Days Inventory for the quarter that ended in Jun. 2026 was 23.04.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cencora's Inventory Turnover for the quarter that ended in Jun. 2026 was 3.96.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cencora's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.24.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cencora's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora Change In Inventory Related Terms
Cencora Change In Inventory Historical Data
* Premium members only.
The historical data trend for Cencora's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1,107 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of €-1,107 Mil mean?
Cencora (MIL:1COR) has a Change In Inventory of €-1,107 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cencora and its competitors.
Is Cencora's Change In Inventory too high?
Cencora's current Change In Inventory is €-1,107 Mil. Overall, Cencora has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Change In Inventory compare to CAH and MCK?
Cencora's Change In Inventory of €-1,107 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Distribution company?
A good Change In Inventory depends on the Medical Distribution industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cencora and its competitors. Cencora's current Change In Inventory is €-1,107 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (MIL:1COR) is currently considered Fairly Valued. The stock's GF Value™ is €257.47, compared to a current price of €271.90 — trading 5.6% above its estimated fair value. The current Change In Inventory is €-1,107 Mil. Cencora's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Cencora (MIL:1COR), the current Change In Inventory is €-1,107 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (MIL:1COR) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be overvalued.
The current stock price of €271.90 is trading 5.6% above its estimated GF Value™ of €257.47.
GuruFocus considers Cencora to be Fairly Valued.
Key valuation signals for MIL:1COR:
Change In Inventory: €-1,107 Mil
GF Value™: €257.47 vs. price of €271.90 (5.6% above fair value)
No single metric tells the full story. See the MIL:1COR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
58GF Score
Get the complete analysis for MIL:1COR
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1COR has been successfully added to your 
